Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FP.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FP.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FD.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FD.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FD.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FD.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FG.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FG.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FG.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FG.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FG.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FG.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.56ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.56ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.56EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.56EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.56ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.59EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.59ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.59ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.59EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.59EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.59ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used